Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $21.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective boosted by Truist Financial from $20.00 to $21.00 in a research note released on Tuesday morning, Marketbeat reports. Truist Financial currently has a hold rating on the real estate investment trust’s stock.

A number of other brokerages also recently issued reports on SBRA. National Bankshares set a $22.00 price objective on Sabra Healthcare REIT in a research note on Friday, October 17th. Jefferies Financial Group reaffirmed a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Saturday, January 3rd. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective on the stock. Finally, Wells Fargo & Company upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $21.11.

Sabra Healthcare REIT Trading Down 1.5%

Shares of SBRA stock opened at $19.02 on Tuesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19. The company has a market cap of $4.74 billion, a price-to-earnings ratio of 26.42, a PEG ratio of 1.18 and a beta of 0.67. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $19.97. The firm has a fifty day moving average price of $19.05 and a 200-day moving average price of $18.69.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The company had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. During the same period in the previous year, the business earned $0.37 earnings per share. Sabra Healthcare REIT’s quarterly revenue was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.3%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 166.67%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in SBRA. Vanguard Group Inc. grew its position in shares of Sabra Healthcare REIT by 0.5% during the third quarter. Vanguard Group Inc. now owns 34,948,785 shares of the real estate investment trust’s stock valued at $651,445,000 after purchasing an additional 179,670 shares in the last quarter. Geode Capital Management LLC boosted its stake in Sabra Healthcare REIT by 0.8% during the second quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust’s stock valued at $121,960,000 after buying an additional 55,200 shares during the last quarter. Bank of America Corp DE grew its holdings in Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after buying an additional 447,528 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Sabra Healthcare REIT by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust’s stock worth $76,988,000 after acquiring an additional 60,843 shares during the last quarter. Finally, Northern Trust Corp increased its stake in Sabra Healthcare REIT by 1.1% in the 3rd quarter. Northern Trust Corp now owns 3,930,245 shares of the real estate investment trust’s stock worth $73,260,000 after acquiring an additional 43,927 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.